{"meshTagsMajor":["Cervical Intraepithelial Neoplasia","Papillomaviridae","Uterine Cervical Neoplasms"],"meshTags":["Cervical Intraepithelial Neoplasia","Female","Humans","Incidence","Papillomaviridae","Papillomavirus Infections","Papillomavirus Vaccines","Risk Factors","Uterine Cervical Neoplasms"],"meshMinor":["Female","Humans","Incidence","Papillomavirus Infections","Papillomavirus Vaccines","Risk Factors"],"genes":["interferon"],"organisms":["10566","9606","63011"],"publicationTypes":["English Abstract","Journal Article","Review"],"abstract":"It has been seen an increase of the cervical cancer and of intraepithelial cancer in the last years. The most important risk factors for cervical cancer are sexual conduct, early of sexual relationships, number of partners, cigarettes, oral anticonceptive, pregnancy, immunosuppression, sexually transmitted illness. And an important role of the Human Papilloma Virus. The HPV has been classified in 3 groups; low risk, the most frequents are 11 and 6, middle risk, tipe 31, 33 and 35, and high risk, 16 and 18, that have frequent association with cervical cancer and with high grade intraepithelial lesions. The cervicovaginal citology is still the most accurate diagnosis method to detect SIL or CIN and invasive cancer in early stages, it is discussed the periodicity and group of women to whom the method must point. There are different options depending if it is a SIL of low or high grade or and cancer. With the possibility of doing follow up or treatment, such as. LLETZ, Laser, Criotraphy, cone and interferon for the preneoplastic lesions. The achievement of a vaccine for HPV could have a significant impact on these pathology.","title":"[Cervical cancer prevention: an update].","pubmedId":"16972742"}